Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group (Q36097717)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group |
scientific article |
Statements
1 reference
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group (English)
1 reference
Richard Gorlick
1 reference
Donald A Barkauskas
1 reference
Karen Marcus
1 reference
David Ebb
1 reference
Paul Meyers
1 reference
Holcombe Grier
1 reference
Mark Bernstein
1 reference
Steven E Lipshultz
1 reference
Mark Krailo
1 reference
Meenakshi Devidas
1 reference
Gene P Siegal
1 reference
William Shay Ferguson
1 reference
George Douglas Letson
1 reference
Allen Goorin
1 reference
Peter Beardsley
1 reference
Neyssa Marina
1 reference
4 June 2012
1 reference
1 reference
2545-2551
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference